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Phillip C. Camp, Jr., MDThe rapid growth in short-term mechanical circulatorysupport has dramatically changed over the past several
years. Twenty years ago, most cardiothoracic programs main-
tained one or two devices that were kept in deep reserve for
the rare patient who experienced postoperative cardiopulmo-
nary collapse and was deemed a potential candidate for a
ventricular assist device. Barely over a decade ago, the ﬁrst
signiﬁcant validation of implantable ventricular devices
appeared in the literature, showing clinical superiority over
best medical therapy. These early lessons in the arena of
mechanical circulatory support led to rapid and dramatic
improvement in technology, knowledge, and clinical skill.
Leaders at many of our best institutions began to understand
that these technologies could likely have an even more far-
reaching and critical inﬂuence for clinical situations, bridging
a patient to one of several possible pathways. In the past few
years, the 4 primary ways by which short-term mechanical
circulatory assistance has been most efﬁciently applied
include the following:(1) Bridge to recovery: This is for postoperative cardiac or
pulmonary failure or both and for transient nonoperative
organ failure that has an expectation of meaningful
recovery if given enough time to overcome the inciting
event.(2) Bridge to transplant: This is fairly well established in the
area of primary cardiac failure but is becoming a far more
important factor in the arena of lung transplantation.(3) Procedural support: In this application, various forms of
mechanical support are deployed either to improve
stability to the patient who requires procedural inter-
vention or prophylactically to the patient who is
expected to develop clinical instability during a potential
clinically problematic procedure.(4) Bridge to decision: Conceptually, this is the most ﬂexible,
dynamic, and newest application of short-term mechan-
ical circulatory assistance. This will likely make up the
largest portion of short-term mechanical circulatory
support in the near future. The rapid advancement of
this technology and its increasingly diverse options in
terms of actual devices and indications are somewhat
juxtaposed to the immediacy of the patient’s clinicalmatter r 2013 Elsevier Inc. All rights reserved.
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midterm and long term mechanical support, if any, is
best applied to that particular clinical indication.Although many of these technologies were developed
speciﬁcally for unique clinical scenarios, because we have
improved and simpliﬁed the technology and better under-
stand how we can deploy devices in the area of
cardiopulmonary mechanical circulatory support, the lines
between traditional applications of technology have
become very blurred. As a result, while there are a large
number of diverse support devices that are currently
available clinically, it is probably better to think of them
globally as technology that provides the spectrum of
support including left ventricular and right ventricular
failure, respiratory failure, or any combination of these. At
our institution, as with many other tertiary hospitals, the
decision-making process is done as part of a multi-
disciplinary team. How we deploy the technology when
short-term support is required is unique to each situation.
It is important to recognize that the breadth of technology
available is often somewhat siloed at many institutions
based on previous experience or technical biases. This is
most pronounced when the full spectrum of providers
(surgeons, cardiologists, interventional pulmonologists,
etc.) do not practice in an integrated manner. Although
these types of technologies provide dramatic capabilities to
stabilize patients with cardiac and pulmonary failure, they
are associated with a necessity for complex, integrated
infrastructures and signiﬁcant capital investment. It is
advised that institutions wishing to deploy these types of
vital, complicated mechanical circulatory support services
do so as a multidisciplinary team.
Typically, an article found here in Operative Techniques
has a running narrative describing a particular technique in
detail. Because short-term mechanical circulatory support
can be deployed for a wide spectrum of clinical problems,
we can review a diverse number of potential applica-
tions of short-term support. Each of the accompanying
illustrations contains a summary that brieﬂy describes
the application and any unique descriptors as indicated
(Figs. 1-8).239
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Figure 1 As mentioned previously, the spectrum of options that exist for short-term mechanical support is directly related to the speciﬁc need at that
particular time, and the type of support can be modiﬁed as the clinical situation evolves (A). In the modern era of short-term mechanical support, the
difference between a “ventricular assist device” and extracorporeal membrane oxygenation (ECMO) generally comes down to the presence or absence
of the gas-exchange device integrated into the mechanical support system. Although traditional views have placed these basic functions as
profoundly separate, in the modern era, these are essential components that are potentially deployed as part of a mechanical circulatory circuit (B).
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Short-term mechanical circulatory support 241Figure 2 The experience with extracorporeal membrane oxygenation (ECM
indications for support have greatly increased. (A) ECMO in its traditi
cannulation has inﬂow and outﬂow from the venous system. Typical
nonoperative patient and postoperative respiratory failure, more common
Nationally, the most common indication for venovenous ECMO is in the
superior vena cava; v ¼ veinO) in adults has rapidly grown over the past couple of years and the
onal application provides only pulmonary support, and typically,
applications for ECMO include isolated respiratory failure in a
ly in the lung transplant ﬁeld and with postcardiotomy syndromes.
nonoperative patient and access is obtained percutaneously. SVC ¼
P.C. Camp Jr.242Figure 2 (Continued) (B) Commonly, the venous drainage cannula is percu
cannula residing just below the diaphragm. The “arterial” or inﬂow cannu
the tip residing in the right atrium. The amount of volume that can be pro
output, is most limited by the size of the cannula and as such, small can
Perhaps one of the most interesting and exciting evolutions of ECMO i
is worthy of a separate chapter but should be brieﬂy mentioned. With
venovenous ECMO support via a single-access cannula in the right intern
waiting for lung transplant from sedation and enroll them in normal da
has been accomplished with implantable VADs when patients are bridg
IVC ¼ inferior vena cava; v ¼ vein.taneously placed by the right or left femoral vein with the tip of the
la is often placed percutaneously through the right jugular vein with
cessed through the ECMO circuit, which never totals actual cardiac
nulas should be avoided whenever possible.
n the past 5 years has been the development of “walking ECMO.” It
the advent of duel-lumen cannulas and thus the ability to provide
al jugular vein, it has become possible to wean patients on ECMO
ily and physical activities. This is, in many ways, a mirror of what
ed to heart transplant (not pictured). SVC ¼ superior vena cava;
Figure 3 While the primary focus of this discussion is on circulatory support, it is important to recall that the essence of all of these devices is to
provide stability and to allow enough time to assess the patient, develop a more deﬁnitive plan of care, and then act on that plan. The intra-
aortic balloon pump continues to be an important ventricular support device by improving coronary perfusion, providing ventricular afterload
reduction, and providing time for deﬁnitive interventions. It can be deployed in addition to other mechanical circulatory devices as well but
must be discontinued in the setting of either venoarterial ECMO support or with retrograde arterial cannulation techniques (refer to Figs. 4-8).
When considering potential use of both, or if sequential support may be prospectively considered, using an access sheath with the intra-aortic
balloon pump is advised because this would prevent groin bleeding if removed or the need for femoral artery cutdown and repair. a ¼ artery.
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P.C. Camp Jr.244Figure 4 Perhaps the most commonly recognized means of mechanical circ
patients presenting with cardiogenic shock demonstrate global dysfunctio
indicated. In the era of rapid transition of patients with severe cardiac dys
laboratory, the ability to deploy percutaneous LVAD can provide substant
need for more deﬁnitive therapies. Aided by high-resolution imaging, ve
femoral vein and perforated across the atrial septum, allowing for isola
placement of an arterial catheter provides inﬂow and the perfusion is ma
cava; v ¼ vein; a ¼ artery.ulatory support is the left ventricular assist device (LVAD). (A) Most
n but only require left ventricular support if mechanical support is
function from the emergency department (ED) to the catheterization
ial improvement in overall stability, time to evaluate recovery, or the
nous drainage cannulas can be percutaneously placed via the right
ted left atrial drainage. Typically, left femoral artery percutaneous
intained by a centripetal variable speed pump. IVC ¼ inferior vena
Short-term mechanical circulatory support 245Figure 4 (Continued) (B) In the setting of left ventricular failure in the oper
continuing short-term support. The ascending aortic cannula is typically
catheter is transitioned to the left atrium. If longer-term support is needed
hope for modest term support, the grafts can be sewn to the aorta as anating room (OR), central cannulation is a well-established means of
maintained from the original operation and the venous drainage
and the patient is not a candidate for implantable LVAD or there is
option (not shown).
P.C. Camp Jr.246Figure 5 In the setting of isolated right ventricular failure, right ventricular assi
infarct, on occasion, the right ventricle can develop substantial dysfunction
biventricular failure. (A) With the expectation that many of these patients will
from RA to MPA is appropriate. A newly developing variant of RVAD supp
hypertension while awaiting lung transplantation. (B) Application of right ventr
been successfully used to unload the RV and provide time for right ventricular
and gas exchange. As this application is potentially longer term, standard
PA ¼ pulmonary artery.st device may be indicated. Although far more common following RCA
following cardiac transplantation. In addition, another indication is
have rapid recovery of RV function (3-5 days), use of standard cannula
ort is for the chronically failing RV in the setting of severe pulmonary
icular support for short-term and midterm bridge to lung transplant has
remodeling while hopefully maintaining acceptable pulmonary perfusion
VAD graft cannulas can be employed for better functional results.
Short-term mechanical circulatory support 247Figure 5 (Continued) (C) With the advent of directable cannulas and im
provided percutaneously when indicated for short-term interventions. In
drainage cannula is typically placed via the right femoral vein; however,
percutaneously placed via the right IJ (or left SCV) and the tip is passe
Although it will not typically be able to support VAD ﬂow totaling
hemodynamic function. (A-C) As all forms of this type of RVAD support
can be converted to provide pulmonary support when needed or so-call
inferior vena cava; LPA ¼ left pulmonary artery; RPA ¼ right pulmonarproved devices with better ﬂuid dynamics, RVAD support can be
a very similar process to venovenous access for ECMO, the venous
the tip ultimately resides in the right atrium. The inﬂow cannula is
d along through the RA and RV and across the pulmonary valve.
the complete cardiac output, it provides signiﬁcantly improved
are externalized, there is an extreme advantage because all of these
ed Oxy-RVAD (not in picture). SVC ¼ superior vena cava; IVC ¼
y artery.
Figure 6 Although most of the devices we have reviewed rely on the external diversion of blood and an external pump, there are several types of
devices that are internalized and use turbine technology. (A) As mentioned in Introduction, there are devices that can be used for circulatory support
in the setting of ventricular dysfunction as well as prophylactically to provide stability during procedures that may be too provocative and would
induce unacceptable instability unless supported. Such turbine devices are typically introduced in a percutaneous manner or via cutdown, and then
placed transvalvularly where the inﬂow opening is within the ventricle and the outﬂow opening is within the subsequent vessel, typically the
ascending aorta. The luminal size of the device is the primary limiting factor in terms of degree of ﬂow and support that can be provided; it currently
cannot provide ﬂow that approaches normal cardiac output. However, there is generally enough ﬂow to help support transient instability during
procedures (e.g., high-risk PCI) in a patient who does not need VAD level support. (B) Although most commonly placed for percutaneous support, it
can be placed centrally in the OR as a means of adjunct support or as a bridge to recovery is needed.
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Figure 7 One of the more interesting adaptations of these new technologies is “pumpless ECMO.” Of patients with severe pulmonary
hypertension who are waiting for lung transplant, a common scenario is the development of profound right ventricular dysfunction and
failure. Often, the patient becomes too ill to remain on the transplant list. Once present, posttransplant outcomes are markedly worse for those
who make it to transplant. As the means of RV failure is the profound vascular resistance of the pulmonary bed, a low-resistance detour is a
means of protecting and recovering the ailing RV. There is a growing experience with using the RV as the “pump” for a modiﬁed ECMO circuit
and diverting blood from the PA, via a gas-exchange device, to the left atrium, thus bypassing the pulmonary vasculature. A graft cannula is
sewn to the MPA, blood (using the pressure generated by the RV) is pumped through a gas-exchange device and allowed to return to the LA.
The simplicity of this centrally placed system dramatically improves overall patient stability, allows remodeling and recovery of the RV, and is
associated with markedly improved short-term and midterm survival following lung transplant. PA ¼ pulmonary artery.
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Figure 8 The ultimate format of cardiopulmonary support is total cardiac and pulmonary support. Earlier, we would call it prolonged
cardiopulmonary bypass (CPB), but currently it is more appropriately referred to as venoarterial extracorporeal life support (ECLS). Although
not unlike CPB in concept, ECLS is a much less complex application of various options that exist for mechanical circulatory support combined
with marked improvement in the gas-exchange devices in terms of durability and efﬁcacy. (A) Cardiothoracic surgeons are most aware of the
application to the patient with globally depressed myocardial function who are unable to wean from CPB. Using cannulation sites from the
original cardiac operation, the patient is simply transitioned from CPB to an ECMO circuit with serial examinations and a hope for recovery in
a few days. Of these types of situations where CPB cannot be weaned, about 4 of 10 survive to discharge with supported with ECLS.
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Figure 8 (Continued) (B) However, the greatest amount of growth in ECLS applied for total cardiopulmonary collapse is not postoperative.
Venoarterial ECLS, typically with right femoral vein percutaneous access (tip in RA) and left femoral artery access, can be very easily and
rapidly initiated in many situations of sudden cardiopulmonary collapse. Common indications are massive PE with instability pending surgery
and amniotic emboli during childbirth. A growing ﬁeld will soon include ECLS as an adjunct for in-hospital cardiac arrest (ED, catheterization
laboratory, etc.). In patients who are candidates for this technology, survival has been shown to improve from 10% with CPR alone up to 37%
when augmented with ECLS. A trained resident can initiate therapy with nothing more than a simple US machine to guide access to vessels.
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